Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.31.231746Source: DataRank Database

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2 is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Download PDF

Cite:

Linked data & code

nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: hybridTopics (44)IDs (PubMed)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Jeff E. Glasgow ORCID,Daniel Limonta ORCID,Paige Solomon,Irene Lui ORCID,Yang Zhang ORCID

Live enrichment

PubMed:33093202

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5K99GM135529-02

Mapping and rewiring protein allostery

National Institutes of Health

Grant: 3P30CA082103-21S2

Cancer Center Support Grant

National Institutes of Health

Grant: 5U19AI111825-02

Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines

National Institutes of Health

Grant: 5R35GM122451-05

Discovering how oncogenes remodel the surfaceome of cells

hybridLicense: CC BY

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.07.31.231746

Unpaywallhttps://doi.org/10.1101/2020.07.31.231746

Europe_PMChttps://europepmc.org/article/PPR/PPR195190

Europe_PMChttps://europepmc.org/api/fulltextRepo?pprId=PPR195190&type=FILE&fileName=EMS92896-pdf.pdf&mimeType=application/pdf

https://doi.org/10.1073/pnas.2016093117

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

570Coronavirusescomputational design610BioengineeringSaccharomyces cerevisiaeProtein EngineeringAntiviral Agentsreceptor trapArticleCoronaviruses Therapeutics and InterventionsPeptide LibraryBiodefense2.1 Biological and endogenous factors2.2 Factors relating to the physical environmentHumansyeast displayLungMultidisciplinaryBinding SitesBiomedical and Clinical Sciences5.2 Cellular and gene therapiesSARS-CoV-2antiviral therapeuticsBiological SciencesSpike GlycoproteinRecombinant ProteinsCoronavirusMolecular Docking SimulationInfectious DiseasesEmerging Infectious DiseasesGood Health and Well BeingHEK293 CellsMedical MicrobiologyDrug DesignMutationSpike Glycoprotein, CoronavirusPneumonia & InfluenzaAngiotensin-Converting Enzyme 2InfectionBiotechnologyProtein Binding

Sustainable Development Goals

SDG 3: 3. Good health

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2

FAIR Checklist

Authors (20)

Funding (5 grants)

Open Access

Topics

Annotations (Europe PMC)